Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI

Trimethylamine N-oxide (TMAO), a metabolite derived from the gut microbiota, is proatherogenic and associated with cardiovascular events. However, the change in TMAO with secondary prevention therapies for ST-segment elevation acute myocardial infarction (STEMI) remains unclear. The purpose of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuzawa, Yasushi, Nakahashi, Hidefumi, Konishi, Masaaki, Sato, Ryosuke, Kawashima, Chika, Kikuchi, Shinnosuke, Akiyama, Eiichi, Iwahashi, Noriaki, Maejima, Nobuhiko, Okada, Kozo, Ebina, Toshiaki, Hibi, Kiyoshi, Kosuge, Masami, Ishigami, Tomoaki, Tamura, Kouichi, Kimura, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690996/
https://www.ncbi.nlm.nih.gov/pubmed/31406181
http://dx.doi.org/10.1038/s41598-019-48246-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690996/
https://www.ncbi.nlm.nih.gov/pubmed/31406181
http://dx.doi.org/10.1038/s41598-019-48246-6

Ejemplares similares